1. Home
  2. VNRX vs MGLD Comparison

VNRX vs MGLD Comparison

Compare VNRX & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNRX
  • MGLD
  • Stock Information
  • Founded
  • VNRX N/A
  • MGLD 1996
  • Country
  • VNRX United States
  • MGLD United States
  • Employees
  • VNRX N/A
  • MGLD N/A
  • Industry
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MGLD Finance/Investors Services
  • Sector
  • VNRX Health Care
  • MGLD Finance
  • Exchange
  • VNRX Nasdaq
  • MGLD Nasdaq
  • Market Cap
  • VNRX 58.6M
  • MGLD 41.9M
  • IPO Year
  • VNRX N/A
  • MGLD N/A
  • Fundamental
  • Price
  • VNRX $0.55
  • MGLD $1.05
  • Analyst Decision
  • VNRX Strong Buy
  • MGLD
  • Analyst Count
  • VNRX 4
  • MGLD 0
  • Target Price
  • VNRX $4.17
  • MGLD N/A
  • AVG Volume (30 Days)
  • VNRX 106.5K
  • MGLD 29.7K
  • Earning Date
  • VNRX 05-12-2025
  • MGLD 05-12-2025
  • Dividend Yield
  • VNRX N/A
  • MGLD N/A
  • EPS Growth
  • VNRX N/A
  • MGLD N/A
  • EPS
  • VNRX N/A
  • MGLD N/A
  • Revenue
  • VNRX $1,285,827.00
  • MGLD $32,057,000.00
  • Revenue This Year
  • VNRX $71,446.31
  • MGLD N/A
  • Revenue Next Year
  • VNRX N/A
  • MGLD N/A
  • P/E Ratio
  • VNRX N/A
  • MGLD N/A
  • Revenue Growth
  • VNRX 97.50
  • MGLD N/A
  • 52 Week Low
  • VNRX $0.43
  • MGLD $0.91
  • 52 Week High
  • VNRX $1.04
  • MGLD $2.10
  • Technical
  • Relative Strength Index (RSI)
  • VNRX 44.08
  • MGLD 46.14
  • Support Level
  • VNRX $0.55
  • MGLD $0.93
  • Resistance Level
  • VNRX $0.65
  • MGLD $1.05
  • Average True Range (ATR)
  • VNRX 0.04
  • MGLD 0.07
  • MACD
  • VNRX -0.00
  • MGLD 0.02
  • Stochastic Oscillator
  • VNRX 16.00
  • MGLD 73.33

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

Share on Social Networks: